ANN ARBOR, Mich., May 02, 2016 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM), a veterinary pharmaceutical company, today announced its shares are now publicly listed on TSX Venture Exchange (TSXV) and posted for trading under the symbol “ZOM”, after receiving final approval from TSXV on April 28, 2016 for its previously disclosed qualifying transaction.
“This is an exciting milestone for Zomedica in its mission to advance animal health and veterinarian success,” stated Zomedica President and CEO Gerald Solensky, Jr. “With our shares trading on TSXV, Zomedica has a more-efficient method for raising capital to bring our veterinarian-focused products to market while concurrently delivering liquidity for shareholders.”
To commemorate today’s trading on TSXV, Zomedica’s management team will join TMX Group representatives on Tuesday, May 3 to open the market. This ceremony will be broadcast live on the Business News Network morning show and live streamed on TMX Group's YouTube channel at https://youtu.be/9npu8SFP1Uc.
About Zomedica
With U.S. operations based in Ann Arbor, Michigan, Zomedica is a veterinary pharmaceutical company targeting health and wellness solutions for companion animals (canine, feline and equine) through a ground-breaking approach that focuses on the unmet needs of clinical veterinarians. Zomedica is building a diversified portfolio of products comprised of the discovery, development and commercialization of innovative drugs alongside novel drug delivery systems, devices and diagnostics. With multiple clinical veterinarians in executive management, it is Zomedica’s mission to give veterinarians the opportunity to lower costs, increase productivity, and grow revenue while better serving the animals in their care. For more information, visit www.ZOMEDICA.com.
Follow Zomedica
- Email Alerts: sign up for investor, product and service alerts at www.ZOMEDICA.com
- LinkedIn: www.linkedin.com/company/zomedica
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of the release.
Except for statements of historical fact relating to Zomedica, the information contained herein constitutes forward-looking statements. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. Except as required by applicable securities requirements, Zomedica undertakes no obligation to update forward-looking statements if circumstances or management's estimates or opinions should change. The reader is cautioned not to place undue reliance on forward-looking statements.